Interest of the Rapid Diagnostic Test in the Management of Streptotoccic Angina in Children
International Journal of Infectious Diseases and Therapy
Volume 5, Issue 1, March 2020, Pages: 9-16
Received: Jan. 21, 2020; Accepted: Feb. 11, 2020; Published: Feb. 21, 2020
Views 394      Downloads 55
Authors
Maryam Mouamin, Microbiology Laboratory of Marrakech Mohamed VI University Hospital Center, Faculty of Medicine and Pharmacy, Qadi Iyyad University, Marrakech, Morocco
Fadl Mrabih Rabou Maoulainaine, Neonatology Department of Marrakech Mohamed VI University Hospital Center, Faculty of Medicine and Pharmacy, Qadi Iyyad University, Marrakech, Morocco
Nabila Soraa, Microbiology Laboratory of Marrakech Mohamed VI University Hospital Center, Faculty of Medicine and Pharmacy, Qadi Iyyad University, Marrakech, Morocco
Article Tools
Follow on us
Abstract
The objective of this work was to evaluate the interest of RDT compared to the scores of clinical presumptions (McIsaac, PCIE, WHO) in the management of angina with SBHGA of the child while referring to the bacteriological culture. We have managed a prospective analytical study carried out over 8 months between July 2012 and February 2013 in the pediatric emergency department of the Mohammed VI UHC in Marrakech in collaboration with four pediatric practices in the liberal sector, in partnership with a Swiss medical research team from the Lausanne childhood Hospital. For each child consulting for acute angina, a clinical information sheet was completed, an RDT was carried out by the examining doctor, then a throat sample used for the classic bacteriological examination was carried out and treated by the microbiology laboratory of the Mohamed VI UHC of Marrakech. 124 children with strong suspicion of strep throat were included in the study. The average age was 6 years and 4 months with a sex ratio of 1.4 in favor of boys. The bacteriological culture demonstrated the group A hemolytic β streptococcus in=45 (36,9%). The analysis of the established clinical scores revealed the a very good sensitivity reaching 100% but with a mediocre specificity not exceeding 7,7% any score combined without notable superiority of one compared to the others. Mc Isaac's score was more positive ≥ 4 since RDT and culture were positive. The RDT showed a sensitivity of 62,2% and a specificity of 96,15% compared to the bacterial culture which is the reference examination. We retained a strong resistance to erythromycin reaching 69% associated with co-resistance to lyncomicin and spiramycinin 30% of cases. The bacterial origin to SBHG A acute angina in children from the city of Marrakech represented a third of the cases. RDT, by its sensitivity, its high specificity, its speed and its reproducibility, offers a very good means of diagnostic and therapeutic orientation and allows initiating early targeted antibiotic treatment to avoid the appearance of complications in the short, medium and long term and remedy the alarming situation of resistance to macrolides in Marrakech.
Keywords
Acute angina, Group A Beta-hemolytic Streptococcus, Clinical Scores, Rapid Diagnostic Test (RDT), Macrolide Resistance
To cite this article
Maryam Mouamin, Fadl Mrabih Rabou Maoulainaine, Nabila Soraa, Interest of the Rapid Diagnostic Test in the Management of Streptotoccic Angina in Children, International Journal of Infectious Diseases and Therapy. Vol. 5, No. 1, 2020, pp. 9-16. doi: 10.11648/j.ijidt.20200501.13
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Kline JA, Runge JW. Streptococcal pharyngitis: review of the physiotherapy, diagnosis and treatment. The Journal of emergency medicine 1994; 665–680.
[2]
E. MALLET. Etiology, clinical expression of angina. Mdd Mal Infect. 1997; 27: 418-23.
[3]
CENTORRM, WHITHERSPOONJM, DALTONHP, BRODYCE, LINKK. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981; 1: 239-246.
[4]
MCISAACWT, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. Canadian medical association journal 1998; 158: 75.83.
[5]
MACISAACWJ, Vivel Goel, Teresa To, Low DE. The validity of a score throat in family practice. Canadian medical journal 2000; 163 (7): 811-815.
[6]
M Bouskraoui, A. Abid. Acute angina. Service de Pédiatrie A, Hôpital Mère-Enfants, CHU Mohamed VI, Université Cadi Ayyad. Rev Mar Mal Enf 2013; 31: 5-15.
[7]
PCIME in developing countries, justification for an integrated strategy. PCIME–OMSWHO/CHS/CAH98./ARev. 1.1999.
[8]
BOUROUS M, AIMADEDINE M, AMINE M, OUEDRAOGO V, BOUSKRAOUI M. Assessment of the burden of angina by general practitioners in Settat (Morocco). Médecine et Maladies Infectieuses 2010; 40: 243-244.
[9]
Integrated Child Care algorithm according to the Ministry of Health of Morocco Direction of Population 2012 Edition.
[10]
S Charachon. Diagnosis and follow-up ORL infections. Le bon usage des examens biologiques. 77; 90.98.
[11]
Cardiovascular diseases. Ministry of Health. Available from: http://www.sante.gov.ma/Programmes/mal_cardio/Pages/default.aspx.
[12]
BISNOAL. Acute pharyngitis: etiology and diagnosis. Pediatrics 1996; 97 (6pt2): 949-54.
[13]
David L. Rheumatic fever, diagnosis and treatment. Archives of Pediatrics. 1998; 5. (6): 681-6.
[14]
DENNY FW Jr. A 45 years prespective on the streptococcus and rheumatic fever: the Edward H. Kass lecture in infectious disease history. Clin Inf Dis 1994; 19: 1110-22.
[15]
SNELLMANL W, STANGH J, STANGJ M, JOHNSON DR, KAPLAN EL. Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. Pediatrics 1993; 91: 1166-70.
[16]
OLIVIER C, and the GRAPH group. Acute Rheumatic Fever (ARF) in France: incidence of a first episode during the period 1995-97 in the 5-14 years old children. 38th ICAAC 1998. Session 144 L, abstract L90.
[17]
KROBER MS, BASS JW, MICHEL SGN. Streptococcal pharyngitis: Placebo-controlled double-blind evaluation of clinical response to penicillin therapy. Jama 1985; 253: 1271-4.
[18]
HARRISON F. WOOD, M. D.; ALVANR. FEINSTEIN, M. D.; ANGELOTARANTA, M. D.; JEANNEA. EPSTEIN, M. D.; RITASIMPSON, B. A. Rheumatic fever in children and adolescents. A long term epidemiologic study of subsequent prophylaxis streptococcal infections and clinical sequelae. III. Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences. Ann Int Med 1964; 60: 31-46.
[19]
DELMAR C. Managing sore throat: a literature review -II- Do antibiotics confer benefit? Med J Austr 1992; 156: 644-9.
[20]
MONNETP. What to do in front of an acute strain. Should we treat all angina? Rev Prat. 1965; 15: 971-6.
[21]
Statements of American Heart Association-Council in rheumatic fever and congenital heart disease: protection of rheumatic fever patients. JAMA. 1953; 151: 141-3.
[22]
SHULMANS. T, GERBERM. A, TANZR R, MARKOVIT ZM. Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J. 1994; 13: 1-7.
[23]
SCHWARZR. H., WIENTZENR. L., PEDRERAF, FEROLIEJ, MELLAGW, GUANDOLOVL.-Penicillin V for group A pharyn-gotonsillitis. A randomized trial of seven vs ten days' therapy. JAMA. 1981; 246: 1790-5.
[24]
DAJANIA. S, BISNOA. L., CHUNGKJ, DURACKDT, GERBERMA, KAPLANEL et al.-Special report. Prevention of rheumatic fever. A statement for health professionals by the committee on rheumatic fever, endocarditis, Kawazaki disease of the council of cardiovascular disease in the young. Circulation. 1988; 78: 1082-6.
[25]
BARONS, BEGUEP. - Antibiotic treatment of angina. Med Mal Infect. 1988; 18: 521-5
[26]
PORTIERH. - What's new in the treatment of angina? Lettre Infectiol. 1996; 11: 43-5.
[27]
COHEN R., LEVYC, DOIT C, DELAROCQUEF, BOUCHERATM, FITOUSSIF, LANGUEJ, BINGENE: Six-day amoxicillin versus ten day penicillin V in group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 1996; 15: 678-82.
[28]
SHVARTZMANP, TABENKINH. ROSENTZWAIGA, DOLGINOVF.-Treatment of streptococcal pharyngitis with amoxicillin once a day. BMJ. 1993; 306: 1170-2.
[29]
Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009; 302: 758-66.
[30]
Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children with sore throat. JAMA 2005; 294: 2315-22.
[31]
Allemand H. Inventory of the consumption of antibiotics France. Resistance to Antibiotics: What is at stake today in the city of Nantes? Table of the CNAM, 19mai2010.
[32]
Goossens H, Elseviers Metal. Outpatient antibiotic use in Europeand association with resistance: across-national data base study. Lancet2005; 365: 579-87.
[33]
BOUROUSM, AIMADEDINEM, AMINEM, OUEDRAOGOV, BOUSKRAOUIM. Inventory of the consumption of antibiotics France. Resistance to Antibiotics: What is at stake today in the city of Nantes? Table of the CNAM Médecine et maladies infectieuses 2010; 40: 243-244.
[34]
Jérémie COHEN. Diagnostic strategies for childhood pharyngitis from rapid diagnostic test to clinical decision rules. Thesis publicly supported on October 2, 2014.
[35]
Buchbinder N, Benzdira A, Belgaid A, Dufour D, Paon J-C, Maurel A et al. Strep throat in pediatric emergencies: performance and impact of a rapid diagnostic test. Original submission. Archive depédiatrie 14 (2007) 1057-1061.
[36]
Benouda A, Sibile S, Ziane Y, Elouenass M, Dahani K, Hassani A. Place of Streptococcus pyogenes in tonsillitis in Morocco and current state of antibiotic sensitivity. Pathol Biol 2009; 57: 76-80.
[37]
Mezghani Maalej S, Rekik M, Boudaouara M, Jardak N, Turki S, Arous R. et al. Acute angina in children in the Sfax region (Tunisia): epidemiology and interest of the rapid diagnostic test. Médecine et maladie infectieuse 40 (2010) 226-231.
[38]
French Agency for the Health Safety of Health Products. Acute Angina. MedMalInfect1999; 29: 227-36.
[39]
Turkheim H. General antibiotic therapy in current practice: angina. General method, recommendation and arguments. Arch Pediatr 2003; 10: 260-71.
[40]
French agency for the health safety of health products. General antibiotic therapy in common practice in upper respiratory infections in adults and children. 2005 Recommendations.
[41]
Gerber Ma, Shulman ST. Rapid diagnosis of pharyngitis caused by group A streptococci. Clin MIcrobiol Rev 2004; 17: 571-80.
[42]
Roe M, Kichiyama C, Davidson K, Schaefer L, Todd J. Comparison of biostar Strep A OIA Optical Immune Assay, Abbott Test Pack Plus Strep A, and culture for selective media for diagnosis of group A strptoccocal pharyngitis. J Clin Microbiol 1995; 33: 1551-1.
[43]
Cohen R, Chaumette L, Bingen E, et al. The future in angina: rapid diagnostic tests. Med Mal Infect 1997; 27: 424-33.
[44]
Committee on infectious deseaces. Group A streptococcal infection. In: Pickering LK, editor. 2000 Red Book. Elk grove village, IL: American Academy of pediatrics 2001. p 526-36.
[45]
Webb KH. Does culture confirmation of hight-sensitivity rapid streptococcal test make sense? A medical decision analysis. Pediatrics 1998; 101: E2.
[46]
Webb KH, Needham CA, Kurtz SR. Use of a hight-sensitivity rapid strep test without confirmation of negative results: 2 years experience. J Fam Pract 2000; 49: 34-8.
[47]
Bisno AL, Gerber MA, Gwaltney Jr. J M, et al. Practice guidelines for the Diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002; 35: 113-25.
[48]
McIsaac WJ, Kellner JD, Aufricht P, et al. Empirical validation of guidelines for the management of pharyngitis in children and adult. JAMA 2004; 291: 1587-95.
[49]
Hall MC, Kieke B, Gonzales R, et al. Spectrum bias of a rapid detection test for group A beta-hemolytic streptococcal pharyngitis in a pedratic population. Pedratics 2004; 114: 182-6.
[50]
Bisno A, Peter GS, Kaplan EL. Diagnosis of strep throat in adults: are clinical criteria really good enought? Clin Infect Dis 2002; 35: 126-9.
[51]
Portier H, Peyramond D, Boucot I, Grappin M, Boibieux A, Pribil C. Assessment of the applicability of the consensus on the management of angina in adults. Med Mal Infect 2001; 31: 388-95.
[52]
Portier H, Payramond D, Boucot I, Pribil C, Grappin M, Chicoye A, et al. Pharmaco-economic evaluation of the use of rapid diagnostic tests in angina. Med Mal Infect 2001; 31: 506-14.
[53]
Jeguirim H. Use of a rapid diagnostic test for blood with group A beta-hemolytic streptococcus in pediatric settings. Doctoral thesis in medicine. Faculty of Medicine of Tunis 2006.
[54]
Bassetti M, Manno E, Collida A, Ferrando A, Gatti G, Ugolotti E et al. Erythromic in resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis 2000; 6: 180-3.
[55]
Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1075–8.
[56]
Seppäla H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenus H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337: 441–6.
[57]
Seppäla H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. The Finnish Study Group for Antimicrobial Resistance. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995; 21: 1378–85.
[58]
Peluchi C, Gregorian L, Galeone C, Esposito S, Huovino P, LittleP et al. Guidelines for the management of acute sore throat. Clin Microbiol Infec2012; 18Suppl1: 1-28.
[59]
Hersh AL, Jackson MA, Hichs LA. Principals of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics 2013; 132: 1146-54.
[60]
Nice. Respiratory tract infections–antibiotic prescribing 2008 [updated July 2008 January 2011]. Available from: http://www.nice.org.uk/CG69.
[61]
Erin H Graf. Can Rapid Molecular Streptococcus pyogenes Testing Lead to Better Antimicrobial Stewardship for Acute Pharyngitis? The Journal of Applied Laboratory Medicine, Volume 4, Issue 2, 1 September 2019, Pages 140–142.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186